Summary of Aflac Incorporated Q4 2025 Earnings Call

1Key Financial Results and Metrics

Q4 Earnings: Net earnings per diluted share of $2.64; adjusted earnings per diluted share of $1.57 (up 0.6% year-over-year).

Full Year Earnings: Net earnings per diluted share of $6.82; adjusted earnings per diluted share of $7.49.

Japan Segment: Net earned premiums in yen declined 1.9% for Q4; underlying earned premiums down 1.2%.

U.S. Segment: Net earned premiums increased by 4%; premium persistency at 79.2%.

Adjusted Return on Equity (ROE): 11.7% (14.5% excluding foreign currency remeasurement).

Capital Management: $3.5 billion in share repurchases and $1.2 billion in dividends for 2025.

2Strategic Updates and Business Highlights

Japan Operations: Strong sales increase of 15.7% in Q4, driven by the launch of the Miraito cancer insurance product. The new medical product, Anshin Palette, received positive reception.

U.S. Operations: Generated nearly $1.6 billion in new sales for 2025, with significant growth in group life and disability products (up 11.3%) and network dental (up 48.8%).

Product Strategy: Focus on third sector protection and innovative products to attract younger consumers. Continued emphasis on maintaining high premium persistency.

Dividends: Board approved a 5.2% increase in the first quarter 2026 dividend.

3Forward Guidance and Outlook

Japan: Expect underlying earned premiums to decline by 1% to 2% in 2026; benefit ratio projected at 60% to 63%.

U.S.: Anticipate net earned premium growth in the lower end of the 3% to 6% range; benefit ratio guidance of 48% to 52%.

Long-term Strategy: Maintain strong capital and liquidity, with ongoing evaluations for potential M&A opportunities.

4Bad News, Challenges, or Points of Concern

Japan Premium Growth: Despite strong sales, premium growth is hindered by high persistency rates leading to a smaller net increase in the in-force block.

Expense Ratios: Increased expense ratios in both Japan (22%) and the U.S. (40.4%) due to higher sales promotion expenses and scaling new business lines.

Investment Income: Variable investment income fell short of long-term expectations, impacting overall profitability.

Market Risks: Concerns about potential increases in surrenders of interest-sensitive products due to rising yen yields.

5Notable Q&A Insights

Japan Surrenders: Management acknowledged potential for increased surrenders due to rising interest rates but noted no significant impact observed yet.

M&A Outlook: While capital flexibility exists, management remains cautious about pursuing M&A due to the niche nature of their market.

Benefit Ratio Dynamics: The decline in benefit ratios is influenced by updated actuarial assumptions and product mix, with expectations of continued pressure from new product introductions.

AI Integration: Aflac is exploring AI to enhance operational efficiency, particularly in claims processing and enrollment, while maintaining a human touch in customer interactions. This summary encapsulates the key takeaways from Aflac's Q4 2025 earnings call, highlighting both the company's strengths and the challenges it faces moving forward.